Chondroitinase treatment
From Wikipedia, the free encyclopedia
 |
This article is an orphan, as few or no other articles link to it. Please introduce links to this page from related articles; suggestions may be available. (February 2009) |
Chondroitinase treatment is a treatment of proteoglycans, a protein in the fluid among cells where (among other things) they affect neural activity (communication, plasticity).[1] Chondroitinase treatment has been shown to allow adults vision to be restored as far as ocular dominance is concerned.[2] Moreover there is some evidence that Chondroitinase could be used for the treatment of spinal injuries.[3]
[edit] See also
[edit] References
- ^ Cambridge Centre for Brain Repair, School of Clinical Medicine, Cambridge Centre for Brain Repair. Plasticity and the extracellular matrix.
- ^ Hensch TK (2005). "Critical period mechanisms in developing visual cortex". Curr. Top. Dev. Biol. 69: 215–37. doi:10.1016/S0070-2153(05)69008-4. PMID 16243601. http://linkinghub.elsevier.com/retrieve/pii/S0070-2153(05)69008-4.
- ^ "Spinal injury regeneration hope.". BBC NEWS, online. Sunday, 17 February, 00:01 GMT. http://news.bbc.co.uk/2/hi/health/7240898.stm. Retrieved 2009-12-31
 |
This biochemistry article is a stub. You can help Wikipedia by expanding it. |
